P0908 : Adherence to ombitasvir/paritaprevir/r, dasabuvir, and ribavirin is >98% in the Sapphire-I and Sapphire-II trials
Year: 2015
Type: conference-abstract
Source: Journal of Hepatology
Authors: T. Hassanein, S. Roberts, S.D. Shafran, M. Makara, M. Bennett, B. Müllhaupt, F. Poordad, S. Ryder, A.M. Di Bisceglie, B. Fu, E. Coakley, B.H. McGovern, G.R. Foster
Institutions: The Alfred Hospital, Alberta Hospital Edmonton, University of Alberta Hospital, Unified Szent István and Szent László Hospital, University Hospital Zurich, The University of Texas at San Antonio Health Science Center, Texas Liver Institute, NIHR Nottingham Digestive Diseases Biomedical Research Unit, Saint Louis University, AbbVie (United States), Queen Mary University of London
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2409561592